H

Helixmith Co Ltd
KOSDAQ:084990

Watchlist Manager
Helixmith Co Ltd
KOSDAQ:084990
Watchlist
Price: 6 040 KRW -2.89% Market Closed
Market Cap: 278.4B KRW

Relative Value

The Relative Value of one Helixmith Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 6 040 KRW, Helixmith Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Helixmith Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
27
Median 3Y
52.5
Median 5Y
72
Industry
8
vs History
vs Industry
Median 3Y
-6.7
Median 5Y
-9.9
Industry
23.5
vs History
vs Industry
Median 3Y
-8.8
Median 5Y
-11.9
Industry
21.9
vs History
vs Industry
Median 3Y
-6
Median 5Y
-6.4
Industry
24.3
vs History
44
vs Industry
65
Median 3Y
1.3
Median 5Y
2
Industry
3.2
vs History
68
vs Industry
37
Median 3Y
41.2
Median 5Y
58.9
Industry
8.1
vs History
74
vs Industry
29
Median 3Y
89.4
Median 5Y
167.3
Industry
10.1
vs History
vs Industry
Median 3Y
-6.2
Median 5Y
-8.8
Industry
5.9
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-7
Industry
6.2
vs History
vs Industry
Median 3Y
-6.9
Median 5Y
-10.1
Industry
7.7
vs History
vs Industry
Median 3Y
-6.3
Median 5Y
-8.6
Industry
6.3
vs History
26
vs Industry
65
Median 3Y
1.1
Median 5Y
1.9
Industry
5.6

Multiples Across Competitors

Competitors Multiples
Helixmith Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Helixmith Co Ltd
KOSDAQ:084990
278.1B KRW 55.9 -34.5 -23.8 -17.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 845 618.3 -160 863.2 -195 339.2 -193 110.2
US
Abbvie Inc
NYSE:ABBV
405.3B USD 6.8 172.6 16.7 23.7
US
Amgen Inc
NASDAQ:AMGN
176.3B USD 4.9 25.2 18.2 18.2
US
Gilead Sciences Inc
NASDAQ:GILD
151B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.8B USD 9.8 31.2 22.9 23.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 081.5 -531.1 -578.4 -562.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.7B USD 5.7 17.9 17 19.3
AU
CSL Ltd
ASX:CSL
83.3B AUD 3.6 18.6 12.6 15.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.7B USD 16.4 1 210.6 163.2 198
NL
argenx SE
XBRU:ARGX
44.3B EUR 14.4 33.9 58.4 60
P/E Multiple
Earnings Growth PEG
KR
H
Helixmith Co Ltd
KOSDAQ:084990
Average P/E: 191.1
Negative Multiple: -34.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 863.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
172.6
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
10%
1.8
AU
CSL Ltd
ASX:CSL
18.6
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 210.6
N/A N/A
NL
argenx SE
XBRU:ARGX
33.9
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
H
Helixmith Co Ltd
KOSDAQ:084990
Average EV/EBITDA: 40.2
Negative Multiple: -23.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 339.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.7
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.2
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.4 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17
11%
1.5
AU
CSL Ltd
ASX:CSL
12.6
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163.2
N/A N/A
NL
argenx SE
XBRU:ARGX
58.4
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
H
Helixmith Co Ltd
KOSDAQ:084990
Average EV/EBIT: 46.4
Negative Multiple: -17.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 110.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.7
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.2
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.9
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -562.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.3
13%
1.5
AU
CSL Ltd
ASX:CSL
15.7
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
198
N/A N/A
NL
argenx SE
XBRU:ARGX
60
N/A N/A